Previous 10 | Next 10 |
SilverBow Resorces Inc. (SBOW) is expected to report $2.36 for Q4 2023 FAT Brands Inc. Class B Common Stock (FATBB) is expected to report for quarter end 2023-12-31 Ecovyst Inc. (ECVT) is expected to report $0.2 for Q4 2023 MYR Group Inc. (MYRG) is expected to report $1.41 for Q4 2023...
2024-02-27 05:30:00 ET Many investors have seen Novavax (NASDAQ: NVAX) as a promising recovery story ever since the biotech launched a plan to cut costs to better match the revenue opportunities ahead of it. Once one of the biggest coronavirus vaccine hopefuls, Novavax's shares soar...
2024-02-25 08:00:00 ET The last week of February promises a dynamic mix of earnings reports across various sectors. In the technology space, investors are eagerly anticipating updates from Salesforce ( NYSE: CRM ), Snowflake ( NYSE: SNOW ), Zoom Video Communications ( NASD...
2024-02-23 11:09:43 ET Summary Novavax, Inc. soars after settling Covid-19 vaccine dispute and positive peer numbers, but the future remains bleak with the cash balance under pressure. The settlement with Gavi requires Novavax to pay $475 million through 2028, potentially totaling...
2024-02-23 06:53:00 ET How to Identify Trends With Penny Stocks to Profit in 2024 Identifying trends in penny stock trading is a pivotal strategy for investors aiming to profit in 2024. The journey to success involves deep research, leveraging technical analysis, and keeping a pulse on ...
2024-02-22 12:18:31 ET More on Novavax Novavax, Inc. (NVAX) CEO John Jacobs Presents at JPMorgan 42nd Annual Healthcare Conference Transcript J.P. Morgan 42nd Annual Healthcare Conference Novavax: Do Not Expect A Turnaround In 2024 Novavax settles COVID-19 va...
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights on February 28, 2024 PR Newswire GAITHERSBURG, Md. , Feb. 20, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advanc...
2024-02-15 05:17:00 ET After a brutal three-year period that saw its shares collapse by 99%, any remaining longtime shareholders of Novavax (NASDAQ: NVAX) are doubtlessly eager for the biotech to finally step out of the shadows of its first "success" and launch its next winner, even...
2024-02-14 11:43:00 ET More on BioNTech, Moderna, etc. Pfizer Stock: It's Time To Buy The Dip Pfizer Is A Great Investment Over The Next Decade; Buy Pfizer: The 6.3% Yield Is A Appealing Federal judge dismisses PhRMA challenge to Medicare price negotiations ...
2024-02-03 05:35:00 ET Everybody loves a good recovery story. You can get in on a promising company, with a potentially bright future ahead, but at a terrific price. And that means you could win big each time this player reports positive news and makes progress toward its goals. Of course, ...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...